Dimension Creatinine Flex reagent cartridge. Material Number: 10872079. Recall
Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.
FDA recall Class II
Ongoing
FDA lists this Class II recall for Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1980-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Mar 18, 2026
- FDA report date
- May 6, 2026
- Quantity in commerce
- 18,080 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.
Affected model & UDI checker
Search the exact identifiers published for Z-1980-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| DF33B. | Dimension Creatinine Flex reagent cartridge. Material Number: 10872079. | Check source notice | 00630414595009 |
| DF33B | Dimension Creatinine Flex reagent cartridge. Material Number: 10872079. | Check source notice | Not specified |
FDA code information
Material Number: 10872079. Model Number: DF33B. UDI: (01)00630414595009(10)GA6307(17)20261103, (01)00630414595009(10)BA7005(17)20270105. Lot Numbers: GA6307, BA7005.
Why was this product recalled?
Siemens Healthcare Diagnostics is recalling certain lots of Dimension Creatinine Flex reagent cartridge (Dimension CRE2) because a potential imprecision in the Dimension CRE2 quality control (QC) and patient sample results using lot numbers GA6307 and BA7005 on the Dimension System. This imprecision may lead to erroneously decreased or increased creatinine patient results
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Siemens Healthcare Diagnostics, Inc. take?
Siemens Healthineers notified consignees on about 03/18/2026 via letter. Consignees were notified of the issue, the hazard involved and instructed to immediately discontinue use of and discard the affected kit lots, each facility should review the recall notification with their Medical Director to determine the appropriate course of action, including for any previously generated results, if applicable, and review inventory to determine the laboratory's replacement needs and communicate that with Siemens Healthineers. Consignees were also instructed to complete and return the Field Correction Effectiveness Check Form provided and retain the letter with laboratory records and forward it to anyone how may have received or used the affected product.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1980-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology